Table 4: The characteristics metabolites related to CHD patients.

MetabolitesChamical shift value valueUpregulation/downregulation

Leucine0.97−3.8670.000
N-Acetyl glycoprotein2.02−2.5520.011
α-Glucose3.53, 5.23, 3.84−3.576/−3.372/−3.1160.000/0.001/0.002
β-Glucose4.64, 3.72, 3.9−3.081/−3.372/−3.4910.002/0.001/0.000
β-Hydroxy isobutyric acid1.22.0820.042
Phenylalanine3.13−3.3220.002
Acetone2.23−2.8600.006
HDL1.26−2.2960.022
Glutamate2.1−3.0300.002
Glutamine2.14, 3.77−2.761/−2.6030.008/0.009
Methylamine2.54−2.4220.019
Lysine1.73−2.1940.028
Tyrosine3.94−2.0740.038
Ornithine3.79−2.4670.014
Taurine3.43−3.9180.000
Proline3.42−3.7470.000
Lactic acid1.33−2.8420.004
Tryptophan3.49−3.6280.000
Threonine1.34−2.0570.040
Aspartic acid2.68−2.3390.023
Valine1.04, 2.28−3.783/−2.7380.000/0.008
Acetyl glutamic acid2.04−3.0470.002
Isoleucine1.01, 1.98, 0.94, 1.26−2.851/−2.731/−2.228/−2.3300.006/0.006/0.026/0.020
Lipids2.22−2.2620.024
Histidine3.25−3.0470.002

Note. Up- or downregulation mean CHD patients group comparing with healthy people group.